ISSUE 1399
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
The CDC has reported that many states are experiencing a higher-than-usual incidence of pertussis this year. The highest incidence has been in infants, but the disease has also occurred in older children, adolescents, and adults. Thirteen pertussis-related deaths were reported through August 24; the majority of these were in infants <3 months old.1
VACCINES — The acellular pertussis vaccine now in use produces a shorter duration of immunity than the whole cell pertussis vaccine that was used in the past.2,3 The US Advisory Committee on Immunization Practices (ACIP) now recommends that children receive routine immunization with diphtheria, tetanus toxoid, and acellular pertussis (DTaP) vaccine at 2, 4, 6, and 15-18 months, and again at 4-6 years, for a total of 5 doses.
Adolescents and Adults – Two vaccines
... moreWould you like to read the rest of this article? Gain access below.
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Article code: 1399a
Electronic, downloadable article - $45